Business · 12/01/2018Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Draft Guidance on Orphan Designation of Pediatric Subpopulations
Summary
The FDA is extending the comment period for its draft guidance on orphan designation for pediatric subpopulations of common diseases, in response to public interest and to allow additional time for comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →